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Abstract  1 
 2 
Background/objectives: The cardiovascular benefit of increasing fruit and vegetable (F&V) 3 
intake following diagnosis of diabetes remains unknown. We aimed to describe how quantity 4 
and variety of F&V intake, and plasma vitamin C, change after diagnosis of diabetes and 5 
examine if these changes are associated with improvements in cardiovascular risk factors. 6 
 7 
Methods: 401 individuals with screen-detected diabetes from the ADDITION-Cambridge 8 
study were followed-up over five-years. F&V intake was assessed by food frequency 9 
questionnaire and plasma vitamin C at baseline, one- and five-years. Linear mixed models 10 
were used to estimate associations of changes in quantity and variety of F&V intake, and 11 
plasma vitamin C, with cardiovascular risk factors and a clustered cardiometabolic risk score 12 
(CCMR), where a higher score indicates higher risk.  13 
 14 
Results: F&V intake increased in year one but decreased by year five whereas variety 15 
remained unchanged. Plasma vitamin C increased at one- and five-years. Each SD increase 16 
(250g between baseline and one-year and 270g between one- and five-years) in F&V intake 17 
was associated with lower waist circumference (-0.92 (95% CI:-1.57, -0.27) cm), HbA1c (-18 
0.11 (-0.20, -0.03) %) and CCMR (-0.04 (-0.08, -0.01)) at one-year and higher HDL-19 
cholesterol (0.04 (0.01, 0.06) mmol/l) at five-years. Increased plasma vitamin C (per SD, 20 
22.5µmol/l) was associated with higher HDL-cholesterol (0.04 (0.01, 0.06) mmol/l) and 21 
lower CCMR (-0.07 (-0.12, -0.03)) between one- and five-years. 22 
 23 
Conclusions: Increases in F&V quantity following diagnosis of diabetes are associated with 24 
lower cardiovascular risk factors. Health promotion interventions might highlight the 25 
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importance of increasing, and maintaining increases in, F&V intake for improved 26 
cardiometabolic health in patients with diabetes. 27 
28 
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Introduction 29 
Type 2 diabetes is a leading cause of premature morbidity and mortality, much of which can 30 
be explained by the increased risk of cardiovascular disease (CVD). Previous studies have 31 
shown that adhering to specific dietary patterns such as the Dietary Approaches to Stop 32 
Hypertension diet (DASH-diet) or the Mediterranean Diet can lower the risk of developing 33 
CVD, even among those at initially high risk i.e. individuals with diabetes. A common theme 34 
underpinning these diets is an emphasis on consuming more fruits and vegetables (F&V). A 35 
large number of studies have demonstrated independent health benefits of a diet rich in 36 
F&V
1–3
, findings which are supported by several studies which examined associations using 37 
plasma vitamin C as an objective biomarker of F&V intake
4,5
. More recently, variety of F&V 38 
intake, independent of quantity, has been considered in relation to risk of diabetes and CVD
6–
39 
8
. To our knowledge, no studies have examined the relationship between repeat measures of 40 
quantity and variety of F&V intake and CVD risk factors among individuals with diabetes 41 
over five-years of follow-up, corroborated using plasma vitamin C levels.  42 
 43 
Using data from the Anglo-Danish-Dutch Study of Intensive Treatment In People with 44 
Screen Detected Diabetes in Primary Care (ADDITION)-Cambridge study, we examined the 45 
longitudinal relationship between quantity and variety of F&V intake and plasma vitamin C 46 
levels with CVD risk factors in participants with diabetes who were followed-up for five-47 
years.   48 
 49 
Methods 50 
Study Design 51 
The design and rationale for the ADDITION-Cambridge study have been reported in detail 52 
elsewhere
9
. In brief, individuals were recruited from 49 general practice (GP) clinics in the 53 
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East of England, UK, for a stepwise diabetes screening programme. Diabetes was diagnosed 54 
according to WHO criteria
10
. Eligible individuals were aged 40-69 years with no known 55 
diabetes and were within the top 25% of a diabetes risk score
9,11
. Exclusion criteria included 56 
being pregnant or lactating, having an illness with a prognosis of death within one year or a 57 
psychiatric illness which was likely to preclude involvement or informed consent. Of the 58 
33,539 individuals who were invited to attend screening, 867 were identified to have diabetes 59 
and agreed to participate in the randomised control trial. The aim of the trial was to compare 60 
intensive treatment of multiple risk factors with routine care in individuals with screen-61 
detected diabetes. Participants were cluster randomised by GP clinic. In the intensive 62 
treatment group practitioners were encouraged to follow a stepwise target-led treatment 63 
regimen to reduce and control CVD risk factors including blood glucose and lipid levels. This 64 
group additionally received theory-based health promotion materials including 65 
encouragement to consume at least five portions of F&V per day.  The routine care group 66 
received care which followed UK national guidelines for diabetes management
12
. Participants 67 
attended for follow-up health assessments after one- and five-years. As there was no 68 
interaction by trial group, we pooled both trial groups and conducted a cohort analysis. 69 
 70 
Ethical approval was obtained from the Eastern Multi-Centre Research Ethics Committee 71 
(reference number 02/5/54) and all participants gave written informed consent. The 72 
ADDITION-Cambridge trial is registered as ISRCTN86769081. 73 
 74 
Fruit and vegetable intake and plasma vitamin C levels 75 
Plasma vitamin C, an objective biomarker of F&V intake
4,13
, was measured using a 76 
Fluoroskan Ascent FL fluorometer. Self-reported F&V intake was assessed using a validated 77 
130-item food frequency questionnaire (FFQ)
14
. Participants were asked to report the 78 
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frequency of food consumption on a nine-point scale ranging from “never or less than once 79 
per month” to “more than six times per day”. Variety of F&V intake was derived by 80 
summing the total number of unique fruit and vegetable items consumed at least once per 81 
week. Possible variety ranged from 0 to 37 items. Quantity of F&V intake was derived by 82 
summing the total quantity (in grams/day) of different F&V consumed over the period of one 83 
week, divided by seven to quantify daily intake. We did not include potatoes in our analyses 84 
as they differ from vegetables in terms of energy and carbohydrate content and are commonly 85 
substituted for cereals rather than vegetables
15
. We also did not include fruit juice as it is not 86 
considered to be equivalent to whole fruit regarding fibre content and satiety value
16
.  87 
 88 
Measurement of cardiovascular risk factors 89 
Baseline, one- and five-year health assessment visits to the study clinic included clinical and 90 
anthropometric measures. HbA1c was measured in venous samples using an ion-exchange 91 
high-performance liquid chromatography method (Tosoh Bioscience, Redditch, UK). Serum 92 
total cholesterol, high density lipoprotein (HDL)-cholesterol and triglycerides were measured 93 
in non-fasted samples using enzymatic techniques (Dade Behring Dimension analyser, 94 
Newark). Blood pressure was determined based on the mean of three measurements 95 
performed after 10 minutes of rest, while participants were seated with a cuff placed on their 96 
predominant arm at the level of the heart, using an automated sphygmomanometer (Omron 97 
M4, UK). Height and weight were measured in light clothing, without shoes, using a fixed 98 
rigid stadiometer and scale (SECA, UK). Waist circumference was derived based on the 99 
mean of two measurements taken with a tape measure halfway between the lowest point of 100 
the rib cage and the anterior superior iliac crest whilst standing.  101 
 102 
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Clustered cardiometabolic risk scores (CCMR) were derived for all clinic visits by averaging 103 
standardised values for waist circumference, systolic blood pressure, HbA1c, the natural log 104 
of triglycerides and the inverse of HDL-cholesterol. Variables were standardised by 105 
subtracting from them sex-specific population means and dividing by sex-specific SDs. 106 
Means and SDs at baseline were used to standardise all follow-up CCMR scores. A lower 107 
score therefore indicates lower risk. 108 
 109 
Covariates 110 
Self-report questionnaires were used to obtain information on age, sex, occupation and 111 
ethnicity. Occupational social class was defined according to the Registrar General’s 112 
occupation-based classification and comprised three categories: “professional, managerial 113 
and technical”, “skilled – manual and non-manual” and “partly skilled or unskilled”. Total 114 
energy and alcohol intake were assessed using an FFQ
14
. Time spent in moderate-to-vigorous 115 
physical activity (MVPA) was assessed by self-report using the previously validated 116 
European Prospective Investigation into Cancer-Norfolk physical activity questionnaire 117 
(EPAQ-2)
17
. Medication use was assessed using a self-report questionnaire adapted from the 118 
Aberdeen Health Service Research Unit questionnaire
9
. Very few people reported taking 119 
multivitamin supplements therefore this was not included in the analysis. 120 
 121 
Statistical analysis 122 
Descriptive characteristics at baseline and at one- and five-years of follow-up were 123 
summarised using means and SDs or frequencies and percentages. t-tests or chi-squared tests 124 
were used to examine differences in participant characteristics between those included for 125 
these analyses and those excluded due to missing data. 126 
 127 
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Linear mixed models, with participant specific random intercepts, were used to estimate the 128 
associations between each SD increase in change in quantity of F&V intake from baseline to 129 
one-year, and from one-year to five-years, with CVD risk factor levels and CCMR at one- 130 
and five-years, respectively. Models were adjusted for age and sex (Model 1), exposure and 131 
outcome at baseline or one-year (where applicable), intervention group, occupational social 132 
class, smoking status, alcohol intake, total energy intake and self-reported MVPA at each 133 
baseline and follow-up (Model 2). We additionally adjusted for use of antihypertensive, lipid-134 
lowering and glucose-lowering medications at each baseline and follow-up in Model 2, as 135 
appropriate. The same approach was used to examine the associations for variety of F&V 136 
intake as well as for plasma vitamin C levels. Associations of quantity of intake were 137 
adjusted for variety and vice versa.  138 
 139 
We assessed for interaction of each exposure with sex in Model 2. To examine whether 140 
associations were mediated by changes in waist circumference (when waist circumference 141 
was not the outcome), we additionally adjusted for changes in waist circumference in Model 142 
2. We also examined whether associations with CCMR were primarily driven by an 143 
association with waist circumference by generating a CCMR score excluding waist 144 
circumference (CCMR•excluding•waist) and with additional adjustment for waist circumference.  145 
 146 
Sensitivity analyses 147 
As the main analyses were limited to individuals who had data for all variables included in 148 
the CCMR score, we also repeated all analyses for each of the cardiometabolic risk factors 149 
independently by including the largest number of participants with data for that risk factor. 150 
To explore the impact of missing covariate data on our results, we also used multiple 151 
imputation by chained equations. For each exposure-outcome relationship, 10 imputed 152 
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datasets were created, and parameter estimates were combined using Rubin’s rules. Each 153 
imputation model included both the outcome of interest and all covariates in the analysis 154 
models.  155 
 156 
All statistical analyses were performed using Stata/SE 13.1 (Stata-Corp, College Station, 157 
TX).  158 
 159 
 160 
Results 161 
In total, 603 individuals attended for all three clinic visits, of whom 401 had complete data 162 
for F&V intake, cardiometabolic risk factor levels and covariates (Supplementary Figure 1). 163 
177 individuals were in the intensive treatment trial group and 224 in the routine care trial 164 
group. The mean age of the study participants was 61.4 (SD 6.6) years at baseline. Men 165 
comprised 57% of the cohort (Table 1). Participants with missing follow-up data tended to 166 
have a larger waist circumference and higher HbA1c levels at baseline compared with those 167 
with complete data. Those with missing data also reported consuming a lower quantity and 168 
variety of F&V and had lower plasma vitamin C levels at baseline and at one- and five-years 169 
of follow-up.  170 
 171 
As shown in Table 1, intake of F&V increased in both men and women over the first year of 172 
follow-up but decreased between one- and five-years. The most commonly eaten fruits were 173 
apples, oranges and bananas and the most commonly eaten vegetables were carrots, peas, 174 
tomatoes and green salad. Variety of F&V intake remained unchanged over one- and five-175 
years of follow-up. Plasma vitamin C levels increased across follow-ups. Quantity and 176 
variety of F&V intake were moderately correlated at each time point (r=0.54, 0.45 and 0.40 at 177 
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baseline, one-year and five-years, respectively). There was a weak correlation between 178 
quantity of vegetable intake and plasma vitamin C (r=0.10-0.19, at all time points) and a 179 
slightly stronger correlation between fruit and combined fruit and vegetable intake and 180 
plasma vitamin C (r=0.24-0.30, at all time points). 181 
 182 
There was no suggestion of interaction by sex (p>0.05) so all results are presented for men 183 
and women combined. Each SD change in quantity of F&V intake between baseline and one-184 
year (250g) was independently associated with a 0.92 (95% CI: 0.27, 1.57) cm lower waist 185 
circumference, a 0.11 (0.03, 0.20) % lower HbA1c level and a 0.04 (0.01, 0.08) lower CCMR 186 
score at one-year (Table 2). Except for HDL-c, F&V intake was not associated with any 187 
other CVD risk factor between one- and five-years. Change in the quantity of fruit intake (per 188 
SD, 192g) was associated with a lower waist circumference (-0.89 (-1.56, -0.23) cm), HbA1c 189 
level (-0.12 (-0.20, -0.03) %) and CCMR (0.04 (0.01, 0.08)) at one-year as well as lower 190 
triglyceride levels (-0.10 (-0.19, -0.01) mmol/l) and higher HDL-c (0.03 (0.01, 0.05) mmol/l) 191 
at five-years (per SD, 197g). In contrast, change in quantity of vegetable intake (per SD, 192 
151g) was associated with a 1.89 (0.29, 3.48) mmHg lower systolic blood pressure at one-193 
year. Increases in plasma vitamin C were not associated with any of the CVD risk factors or 194 
with CCMR between baseline and one-year (Table 2). Between one- and five-years however, 195 
each SD increase in plasma vitamin C (22.5μmol/l) was associated with lower triglyceride 196 
levels (-0.11 (-0.21, -0.01), CCMR (-0.07 (-0.12, -0.03)) and with higher HDL-c levels (0.04 197 
(0.01, 0.06) mmol/l). 198 
 199 
Additional adjustment for waist circumference had no effect on the observed associations. 200 
Associations between change in combined F&V intake and fruit intake separately with 201 
CCMR•excluding•waist were not statistically significant between baseline and one-year but were 202 
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significant between one-year and five-years. The results were similar after adjustment for 203 
waist circumference in the CCMR•excluding•waist model. The associations between change in 204 
plasma vitamin C and CCMR•excluding•waist did not differ from the CCMR score including waist 205 
circumference (data not shown).  206 
 207 
As shown in Table 3, changes in variety of F&V intake combined and separately were not 208 
associated with any of the individual cardiometabolic risk factors or CCMR at one- or five-209 
years.  210 
 211 
Our findings remained unchanged when we included all participants who had complete data 212 
for the cardiometabolic risk factor being analysed (data not shown) and when we performed 213 
the analyses following multiple imputation of covariate data (data not shown). 214 
 215 
Discussion 216 
We demonstrate that while patients with screen-detected diabetes tend to increase the 217 
quantity of F&V they consume in the first year following diagnosis of diabetes, this increase 218 
is not the result of a change in the variety of F&V consumption, and is not maintained long-219 
term. Nevertheless, we show, for the first time, that even modest increases in F&V intake are 220 
associated with clinically meaningful improvements in a number of important CVD risk 221 
factor levels, namely waist circumference, HbA1c and HDL-cholesterol. Increased vegetable 222 
intake is associated with improved systolic blood pressure whereas increased fruit intake is 223 
associated with improved triglyceride levels. These findings are corroborated by the inverse 224 
association between change in plasma vitamin C and overall clustered cardiometabolic risk.   225 
 226 
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Although previous studies have examined the associations between quantity of F&V intake 227 
and CVD
18
, few have done so in a population of people with diabetes with an extended 228 
duration of follow-up
19,20
, and none have examined the association using plasma vitamin C as 229 
a biomarker of F&V intake. Among 10,000 individuals with diabetes who were followed-up 230 
for nine years in the European Prospective Investigation into Cancer and Nutrition (EPIC) 231 
study, each 80g increase in self-reported F&V intake (including legumes) was associated 232 
with a hazard ratio (HR) of 0.88 (95% CI: 0.81, 0.95) for CVD mortality whereas each 80g 233 
increase in fruit was associated with a HR of 0.90 (0.81, 0.91)
19
. In contrast, among 1,400 234 
Japanese adults with diabetes who were followed-up for eight years, Tanaka and colleagues 235 
did not find an association between self-reported F&V intake and incident coronary heart 236 
disease (CHD), although a protective effect on incident stroke was reported
20
. However, 237 
because F&V intake was assessed only at baseline in both studies, the potential benefits of 238 
increases in intake could not be examined.  239 
 240 
To our knowledge, only two other studies have investigated associations between variety of 241 
F&V intake and CVD risk, and while they were both in non-diabetes specific populations, 242 
neither were able to find an association with incident CHD, despite sample sizes of 20,000 243 
and 143,000 with follow-up durations of 10- and 20-years, respectively
8,7
. 244 
 245 
Consistent with our finding that increased fruit intake was associated with a smaller waist 246 
circumference over one year, Bertoia and colleagues show that each increase in daily serving 247 
of fruit and vegetable is associated with a 240g and 110g reduction in weight, respectively, 248 
over four-years of follow-up
21
. To put only this finding into clinical context, if everybody 249 
with newly developed diabetes were to increase their quantity of F&V intake by 250g per day 250 
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(1 SD in our study), they would experience an approximate reduction in waist circumference 251 
of 1 cm – the benefit of which would be a 2% reduction in the risk of cardiovascular event22.  252 
 253 
Although the associations between plasma vitamin C levels and cardiovascular risk factor 254 
levels were not discrepant with those for quantity of F&V intake, there are several reasons 255 
which might explain why the associations were weaker for plasma vitamin C when the 256 
opposite might have been expected
4
. Firstly, because an increasing number of foods are 257 
enriched with vitamin C, F&V can no longer be assumed to be the main source of intake of 258 
this vitamin. Secondly, plasma levels of vitamin C plateau at the upper end of the normal 259 
range
23
, meaning that any additional increase in intake will not be correctly reflected in 260 
plasma levels. Finally, a number of factors such as physical activity, BMI and the efficiency 261 
with which the body metabolises vitamin C, which is partially genetically determined, have 262 
all been associated with plasma vitamin C levels
24
. Thus, to gain a better understanding of the 263 
association between F&V intake and cardiovascular risk factor levels, future studies should 264 
use a complementary approach in which several F&V biomarkers are used in combination, as 265 
has been done previously
25
.  266 
 267 
Whilst the mechanisms by which F&V might improve cardiovascular risk factor levels are 268 
not yet fully understood, there are several plausible hypotheses. F&V provide an abundant 269 
source of vitamins, minerals and phytochemicals which could help reduce cardiovascular risk 270 
factor levels, by acting both alone and in synergy, by counteracting the potentially harmful 271 
effects of oxidative stress
26
. A second explanation could be that that because F&V generally 272 
have a low energy content any increase in intake could displace energy dense foods from the 273 
diet
27
, thereby aiding weight-loss.   274 
 275 
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Strengths and Limitations 276 
Our study has a number of important strengths, including the population-based study design, 277 
use of repeat measures of all exposures and outcomes over five-years of follow-up and 278 
complementary analyses using plasma vitamin C as an objective biomarker of F&V intake. 279 
While it is known that F&V intake reported using an FFQ generally leads to an over-280 
estimation of intake in comparison to a seven-day dietary recall questionnaire
28
, an additional 281 
major strength of our study is that we used the FFQ across time points to estimate change in 282 
intake, for which it has been shown to be equally as valid as multiple 24-hour recalls
29
. 283 
However, as with any self-reported measure, FFQs may be vulnerable to recall and social 284 
desirability biases. We were also able to adjust for a wide range of potential confounders, 285 
reducing the likelihood that our findings are explained by confounding.  286 
 287 
The limitations of our study also warrant discussion. Our analyses were limited to only 46% 288 
of the original ADDITION-Cambridge study population due to missing data at one or more of 289 
the follow-up clinic visits. Excluded participants reported having a lower intake of F&V, a 290 
larger waist circumference and higher HbA1c levels at baseline. However, when we performed 291 
multiple imputation analyses, the results were similar suggesting bias due to missing data is 292 
unlikely. In addition, due to the number of hypothesis tests conducted, statistically significant 293 
results may have occurred due solely to the play of chance. As the majority of our population 294 
is white and middle-aged, the generalisability of our findings to other ethnicities and age 295 
groups requires caution. Furthermore, due to the lack of heterogeneity in variety of F&V 296 
intake observed in our study cohort, we cannot rule out variety in intake as playing an 297 
important role in CVD – we therefore suggest that this be studied in future cohorts. 298 
 299 
Conclusions 300 
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Increased intake of F&V early in the course of diabetes is associated with improvements in a 301 
number of important cardiovascular risk factors. It will be beneficial to investigate why the 302 
early increases in F&V intake are not maintained in the longer term and future research 303 
should focus on identifying strategies to help patients maintain improvements in diet. 304 
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